Video: IMBRUVICA (ibrutinib) in Combination With Rituximab for Waldenstrom’s Macroglobulinemia

The following link is to the Cancer Therapy Advisor website featuring the following video

IMBRUVICA (ibrutinib) in Combination With Rituximab for Waldenstrom’s Macroglobulinemia

Meletios Dimopoulos, MD, discusses his findings at the ASCO 2018 meeting in Chicago.

Full link:

https://www.cancertherapyadvisor.com/asco-2018/imbruvica-ibrutinib-combination-rituximab-waldenstrom-macroglobulinemia/article/770910/